Explore
Subscribe
Search
My Reads
e-paper
New
Notifications
Newsletters
IFSC Code Finder
New
MintGenie
For You
Top Sections
News
Companies
News
Start-ups
Company Results
People
Technology
Gadgets
Tech Reviews
App News
Foldable Smartphones
5G Tech
Markets
Stock Markets
Commodities
Mark To Market
IPO
Live Blog
Money
Personal Finance
Q&A
Opinion
Photos
Mutual Funds
Mint 50 - Top Mutual Funds
News
Insurance
Lounge
Opinion
Views
Columns
Blogs
Budget 2022
Budget News
Budget Expectations
Budget Videos
Opinion
Auto News
Sports
Industry
Banking
Infotech
Infrastructure
Agriculture
Manufacturing
Energy
Retail
Videos
India Investment Summit
Annual Banking Conclave
Mint Explainers
Market Analysis
Why Not Mint Money
Business of Entertainment
Long Story Capsule
Mint Views
Start-Up Diaries
Money With Monika
Mint Insight
Digital Gurus
Brand Masters
Politics
Education
Impact Feature
Brand Stories
Podcast
Explore Mint
About Us
Contact Us
SITEMAP
Terms of Use
Subscriber - Terms of Use
Cookie Policy
Print Subscription
Privacy Policy
Disclaimer
Mint Code
Code of ethics
Mint Apps
Copyright © HT Digital Streams Limited All rights reserved.
OPEN APP
Showing
255
results for
Premium
Biz as usual for Indian pharma cos despite Russia-Ukraine war
2 min read
.
Updated: 22 Mar 2022
Premium
Russian President Putin might have to stop his botox treatment. Here's why
1 min read
.
Updated: 18 Mar 2022
Premium
Novartis CEO sees ‘better place’ with Covid by year-end
1 min read
.
Updated: 18 Jan 2022
Premium
Novartis wins US court appeal after challenge to Gilenya patent
1 min read
.
Updated: 04 Jan 2022
Premium
Novartis to buy gene-therapy company targeting eye condition
2 min read
.
Updated: 22 Dec 2021
Premium
Novartis to buy back up to $15 billion of its shares
1 min read
.
Updated: 16 Dec 2021
Premium
Novartis rethinks sales strategy for new cholesterol drug launch
5 min read
.
Updated: 22 Nov 2021
Premium
Stocks to watch: Zomato, Yes Bank, Oil India
2 min read
.
Updated: 11 Nov 2021
Premium
Novartis to sell stake back to Roche for $20.7 billion
1 min read
.
Updated: 04 Nov 2021
Premium
Novartis weighs sale or spinoff of generic drug unit Sandoz
2 min read
.
Updated: 26 Oct 2021
Recommended For You
Feedback
Select your Category
Query
Suggestion
Your Message
No Network
Server Issue
Internet Not Available
Wait for it…
Log in to our website to save your bookmarks. It'll just take a moment.
Yes, Continue
×
Edit Profile
Get alerts on WhatsApp
Set Preferences
My Reads
Feedback
Redeem a Gift Card
Logout